{"count": 6, "results": [{"_id": "33910506", "pmid": 33910506, "pmcid": "PMC8080413", "title": "Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana", "journal": "BMC Nephrol", "authors": ["Okyere P", "Ephraim RKD", "Okyere I", "Attakorah J", "Serwaa D", "Essuman G", "Abaka-Yawson A", "Adoba P"], "date": "2021-04-28T00:00:00Z", "doi": "10.1186/s12882-021-02336-8", "meta_date_publication": "2021 Apr 28", "meta_volume": "22", "meta_issue": "1", "meta_pages": "156", "score": 50261.805, "text_hl": "The records of 82 @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@ was used for this study. ", "citations": {"NLM": "Okyere P, Ephraim RKD, Okyere I, Attakorah J, Serwaa D, Essuman G, Abaka-Yawson A, Adoba P. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana BMC Nephrol. 2021 Apr 28;22(1):156. PMID: 33910506", "BibTeX": "@article{33910506, title={Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana}, author={Okyere P and Ephraim RKD and Okyere I and Attakorah J and Serwaa D and Essuman G and Abaka-Yawson A and Adoba P}, journal={BMC Nephrol}, volume={22}, number={1}, pages={156}}"}}, {"_id": "25399733", "pmid": 25399733, "title": "Blood pressure in early autosomal dominant polycystic kidney disease.", "journal": "N Engl J Med", "authors": ["Schrier RW", "Abebe KZ", "Perrone RD", "Torres VE", "Braun WE", "Steinman TI", "Winklhofer FT", "Brosnahan G", "Czarnecki PG", "Hogan MC", "Miskulin DC", "Rahbari-Oskoui FF", "Grantham JJ", "Harris PC", "Flessner MF", "Bae KT", "Moore CG", "Chapman AB", "HALT-PKD Trial Investigators"], "date": "2014-12-11T00:00:00Z", "doi": "10.1056/NEJMoa1402685", "meta_date_publication": "2014 Dec 11", "meta_volume": "371", "meta_issue": "24", "meta_pages": "2255-66", "score": 50081.664, "text_hl": "CONCLUSIONS: In early @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@, the combination of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ did not significantly alter the rate of increase in total kidney volume. ", "citations": {"NLM": "Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB, HALT-PKD Trial Investigators. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11;371(24):2255-66. PMID: 25399733", "BibTeX": "@article{25399733, title={Blood pressure in early autosomal dominant polycystic kidney disease.}, author={Schrier RW and Abebe KZ and Perrone RD and Torres VE and Braun WE and Steinman TI and Winklhofer FT and Brosnahan G and Czarnecki PG and Hogan MC and Miskulin DC and Rahbari-Oskoui FF and Grantham JJ and Harris PC and Flessner MF and Bae KT and Moore CG and Chapman AB and HALT-PKD Trial Investigators}, journal={N Engl J Med}, volume={371}, number={24}, pages={2255-66}}"}}, {"_id": "25399731", "pmid": 25399731, "title": "Angiotensin blockade in late autosomal dominant polycystic kidney disease.", "journal": "N Engl J Med", "authors": ["Torres VE", "Abebe KZ", "Chapman AB", "Schrier RW", "Braun WE", "Steinman TI", "Winklhofer FT", "Brosnahan G", "Czarnecki PG", "Hogan MC", "Miskulin DC", "Rahbari-Oskoui FF", "Grantham JJ", "Harris PC", "Flessner MF", "Moore CG", "Perrone RD", "HALT-PKD Trial Investigators"], "date": "2014-12-11T00:00:00Z", "doi": "10.1056/NEJMoa1402686", "meta_date_publication": "2014 Dec 11", "meta_volume": "371", "meta_issue": "24", "meta_pages": "2267-76", "score": 50077.18, "text_hl": "METHODS: In this double-blind, placebo-controlled trial, we randomly assigned 486 @SPECIES_9606 @@@patients@@@, 18 to 64 years of age, with @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@ (estimated glomerular filtration rate [GFR], 25 to 60 ml per minute per 1.73 m(2) of body-surface area) to receive an ACE inhibitor (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) and placebo or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and an ARB (@CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@), with the doses adjusted to achieve a blood pressure of 110/70 to 130/80 mm Hg. ", "citations": {"NLM": "Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD, HALT-PKD Trial Investigators. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11;371(24):2267-76. PMID: 25399731", "BibTeX": "@article{25399731, title={Angiotensin blockade in late autosomal dominant polycystic kidney disease.}, author={Torres VE and Abebe KZ and Chapman AB and Schrier RW and Braun WE and Steinman TI and Winklhofer FT and Brosnahan G and Czarnecki PG and Hogan MC and Miskulin DC and Rahbari-Oskoui FF and Grantham JJ and Harris PC and Flessner MF and Moore CG and Perrone RD and HALT-PKD Trial Investigators}, journal={N Engl J Med}, volume={371}, number={24}, pages={2267-76}}"}}, {"_id": "21266204", "pmid": 21266204, "title": "Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.", "journal": "Contemp Clin Trials", "authors": ["Cadnapaphornchai MA", "George DM", "Masoumi A", "McFann K", "Strain JD", "Schrier RW"], "date": "2011-05-01T00:00:00Z", "doi": "10.1016/j.cct.2011.01.008", "meta_date_publication": "2011 May", "meta_volume": "32", "meta_issue": "3", "meta_pages": "437-45", "score": 50067.734, "text_hl": "Here we describe our ongoing randomized double-blind placebo-controlled phase III clinical trial to assess the effect of @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ treatment on @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@renal and cardiovascular disease@@@ progression in 107 children and young adults age 8-22 years with @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@ who are receiving the @GENE_ACE @GENE_1636 @@@angiotensin converting enzyme@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Cadnapaphornchai MA, George DM, Masoumi A, McFann K, Strain JD, Schrier RW. Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants. Contemp Clin Trials. 2011 May;32(3):437-45. PMID: 21266204", "BibTeX": "@article{21266204, title={Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.}, author={Cadnapaphornchai MA and George DM and Masoumi A and McFann K and Strain JD and Schrier RW}, journal={Contemp Clin Trials}, volume={32}, number={3}, pages={437-45}}"}}, {"_id": "1317477", "pmid": 1317477, "title": "Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.", "journal": "Kidney Int", "authors": ["Watson ML", "Macnicol AM", "Allan PL", "Wright AF"], "date": "1992-01-01T00:00:00Z", "doi": "10.1038/ki.1992.28", "meta_date_publication": "1992 Jan", "meta_volume": "41", "meta_issue": "1", "meta_pages": "206-10", "score": 50066.72, "text_hl": "The renal and systemic hemodynamic response to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, an @GENE_AP2B1 @GENE_163 @@@angiotension converting enzyme@@@ (@GENE_AP2B1 @GENE_163 @@@ACE@@@) inhibitor, in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@ without @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal failure@@@ was compared with the response in matched unaffected family members. ", "citations": {"NLM": "Watson ML, Macnicol AM, Allan PL, Wright AF. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int. 1992 Jan;41(1):206-10. PMID: 1317477", "BibTeX": "@article{1317477, title={Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.}, author={Watson ML and Macnicol AM and Allan PL and Wright AF}, journal={Kidney Int}, volume={41}, number={1}, pages={206-10}}"}}, {"_id": "24721893", "pmid": 24721893, "title": "Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.", "journal": "Clin J Am Soc Nephrol", "authors": ["Cadnapaphornchai MA", "George DM", "McFann K", "Wang W", "Gitomer B", "Strain JD", "Schrier RW"], "date": "2014-05-01T00:00:00Z", "doi": "10.2215/CJN.08350813", "meta_date_publication": "2014 May", "meta_volume": "9", "meta_issue": "5", "meta_pages": "889-96", "score": 50054.8, "text_hl": "DESIGNS, SETTING, PARTICIPANTS, & MEASUREMENTS: There were 110 pediatric participants with @<m>DISEASE_Polycystic_Kidney_Autosomal_Dominant</m> @DISEASE_MESH:D016891 @@@ADPKD@@@ and normal kidney function receiving @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ who were randomized to treatment with @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ or placebo for a 3-year period with evaluation at 0, 18, and 36 months. ", "citations": {"NLM": "Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2014 May;9(5):889-96. PMID: 24721893", "BibTeX": "@article{24721893, title={Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.}, author={Cadnapaphornchai MA and George DM and McFann K and Wang W and Gitomer B and Strain JD and Schrier RW}, journal={Clin J Am Soc Nephrol}, volume={9}, number={5}, pages={889-96}}"}}]}